FindTrial
Sign In

Potassium Iodide

DRUG9 trials

Sponsors

Cellectar Biosciences Inc., Cellectar Biosciences Inc., University Hospital, Toulouse, University of Massachusetts, Worcester, Kuwait University, New Approaches to Neuroblastoma Therapy Consortium

Conditions

Dentine CariesGraves DiseaseHyperthyroidismIodine BioavailabilityMetastatic PheochromocytomaNeuroblastomaPregnancyRelapsed Neuroblastoma

Phase 1

MIBG With Dinutuximab +/- Vorinostat
CompletedNCT03332667
New Approaches to Neuroblastoma Therapy ConsortiumNeuroblastoma
Start: 2018-09-12End: 2024-02-23Updated: 2025-04-16

Phase 2

An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients with Waldenstrom Macroglobulinemia (CLOVER-WaM)
Active, not recruitingCTIS2023-508671-37-00
Cellectar Biosciences Inc., Cellectar Biosciences Inc.Waldenstrom Macroglobulinemia
Start: 2021-12-02Target: 12Updated: 2025-01-10

Phase 3

Preventing Lack of Iodine During Pregnancy
TerminatedNCT00379535
University Hospital, ToulousePregnancy
Start: 2006-12-31End: 2010-06-30Target: 374Updated: 2011-10-12

Phase 4

Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
CompletedNCT00946296
University of Massachusetts, WorcesterGraves Disease, Hyperthyroidism
Start: 2005-04-30End: 2013-04-30Updated: 2015-12-15

Unknown Phase

Diamine Silver Fluoride and Potassium Iodide
CompletedNCT02771704
Kuwait UniversityDentine Caries
Start: 2015-10-31End: 2016-02-29Updated: 2016-06-09
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
NCT03649438
University of Texas Southwestern Medical CenterMetastatic Pheochromocytoma, Relapsed Neuroblastoma
Updated: 2024-12-11
Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects
CompletedNCT04686006
Kyushu UniversityGraves Disease
Start: 1996-04-01Updated: 2020-12-28
Seaweed, the Food Matrix, and Iodine Bioavailability
NCT04867291
University of GlasgowIodine Bioavailability
Start: 2021-04-30End: 2021-11-30Target: 12Updated: 2021-04-30
Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples
Not yet recruitingNCT05628506
Prof. Gerasimos SykiotisThyroid
Start: 2023-01-01End: 2026-02-11Target: 20Updated: 2022-11-28

Related Papers

Phase I study of <sup>131</sup>I-MIBG with dinutuximab for patients with relapsed or refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.
Journal of Clinical Oncology2022-06-013 citations